Sundrug Co Ltd (SDGCF)
OTHER OTC:SDGCF
SDGCF Stock Chart & Stats
$25.96
$0.00(0.00%)
At close: 4:00 PM EDT
$25.96
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$21.52 - $36.11
Previous CloseN/A
Volume176.00
Average Volume (3M)0.00
Market Cap
$2.85B
Enterprise Value$429.09B
Total Cash (Recent Filing)$62.98B
Total Debt (Recent Filing)$44.22B
Price to Earnings (P/E)14.1
Beta-0.02
Next Earnings
May 15, 2026EPS Estimate
-0.87Next Dividend Ex-DateN/A
Dividend Yield3.31%
Share Statistics
EPS (TTM)0.48
Shares Outstanding119,331,184
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio2.88
Price to Book (P/B)1.83
Price to Sales (P/S)0.61
P/FCF Ratio63.83
Enterprise Value/Market Cap150.74
Enterprise Value/Revenue0.53
Enterprise Value/Gross Profit2.11
Enterprise Value/Ebitda6.75
Forecast
1Y Price Target
$29.65Price Target Upside14.20% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)1.85
Revenue Forecast (FY)$5.73B
Bulls Say, Bears Say
Bulls Say
Consistent Revenue And Profit GrowthSundrug has delivered steady top-line expansion (6.66% year) and positive EPS trends, supported by Fundamentals revenue growth ~5.6%. Durable demand across retail and pharmacy reduces reliance on one product line, indicating expanding market reach and stable organic growth over months.
Low Leverage And Strong Equity BaseA debt-to-equity of 0.14 and 60.7% equity ratio signal conservative capital structure that supports resilience and strategic flexibility. With ROE ~11.4%, the company efficiently uses equity while keeping leverage low, reducing refinancing and solvency risk across multi-month horizons.
Strong Cash GenerationVery strong recent free cash flow growth and an operating cash flow to net income >1 indicate high quality earnings and effective working capital management. These cash metrics provide capacity for reinvestment, dividends or selective store expansion without heavy external financing.
Bears Say
Relatively Low Net Profit MarginA net margin under 4% reflects the low-margin nature of drugstore retail and dispensing services. Persistently thin net margins leave limited buffer for input cost inflation or reimbursement cuts, making long-term profitability sensitive to pricing pressure and cost inflation.
Weak FCF-to-net-income ConversionDespite strong operating cash growth, only ~25% of reported net income converts to free cash flow, limiting cash available for capex, acquisitions, or larger shareholder returns. Structural constraints in converting earnings to free cash could hamper flexibility if investment needs rise.
Exposure To Reimbursement And Regulatory RiskA material portion of pharmacy revenue depends on reimbursement rules and dispensing fees subject to policy changes. Structural regulatory risk can compress margins or alter volumes long-term, making earnings and cash flow sensitive to government pricing and reimbursement adjustments.
Sundrug Co News
SDGCF FAQ
What was Sundrug Co Ltd’s price range in the past 12 months?
Sundrug Co Ltd lowest stock price was $21.52 and its highest was $36.11 in the past 12 months.
What is Sundrug Co Ltd’s market cap?
Sundrug Co Ltd’s market cap is $2.85B.
When is Sundrug Co Ltd’s upcoming earnings report date?
Sundrug Co Ltd’s upcoming earnings report date is May 15, 2026 which is in 30 days.
How were Sundrug Co Ltd’s earnings last quarter?
Sundrug Co Ltd released its earnings results on Feb 12, 2026. The company reported $0.481 earnings per share for the quarter, missing the consensus estimate of $0.523 by -$0.041.
Is Sundrug Co Ltd overvalued?
According to Wall Street analysts Sundrug Co Ltd’s price is currently Undervalued.
Does Sundrug Co Ltd pay dividends?
Sundrug Co Ltd pays a Semiannually dividend of $0.42 which represents an annual dividend yield of 3.31%. See more information on Sundrug Co Ltd dividends here
What is Sundrug Co Ltd’s EPS estimate?
Sundrug Co Ltd’s EPS estimate is -0.87.
How many shares outstanding does Sundrug Co Ltd have?
Sundrug Co Ltd has 119,331,184 shares outstanding.
What happened to Sundrug Co Ltd’s price movement after its last earnings report?
Sundrug Co Ltd reported an EPS of $0.481 in its last earnings report, missing expectations of $0.523. Following the earnings report the stock price went down -0.83%.
Which hedge fund is a major shareholder of Sundrug Co Ltd?
Currently, no hedge funds are holding shares in SDGCF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Sundrug Co Ltd
Sundrug Co.,Ltd. operates and manages drug stores and dispensing pharmacies in Japan. It also operates discount stores that offers food, cosmetics, home appliances, clothing, car supplies, sports and goods, alcoholic beverages, and pharmaceutical products, as well as fresh food, kerosene, etc. The company was founded in 1957 and is headquartered in Fuchu, Japan.
SDGCF Stock 12 Month Forecast
Average Price Target
$29.65
▲(14.20% Upside)
Technical Analysis
Sugi Holdings Co
―
TSURUHA Holdings
―
Create SD Holdings Co., Ltd.
―
COSMOS Pharmaceutical Corporation
―
KUSURI NO AOKI HOLDINGS CO.,LTD.
―
Ownership Overview
―
Insiders
5.03% Mutual Funds
― Other Institutional Investors
91.62% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---